IOTN Working Groups

The Immuno-Oncology Translational Network (IOTN) is a consortium to accelerate translation of basic discoveries to clinical applications to improve immunotherapy outcomes for both “hot” and “cold” cancers - and to prevent cancers before they occur. The implementation plan of the IOTN is to focus on leveraging the expertise and resources of a collaborative network to develop improved immunotherapy and immunoprevention approaches - including novel combinations. Towards this goal, the IOTN has formed a number of cross-cutting functional Working Groups to network across the IOTN with the broad goals to identify and address barriers to progress, and pioneer advances in the field.

 

Each of the Working Groups will develop a Mission Statement.

 

Please check back later for updates on the progress of the IOTN Working Groups!

 

BIOINFORMATICS & COMPUTATIONAL BIOLOGY WORKING GROUP ▼

Chair: Yi Xing, PhD - Children's Hospital of Philadelphia

Co-Chair: Eliezer Van Allen, MD - Dana-Farber Cancer Institute

 

NIH Staff Members

Kevin Howcroft (NCI)

 Lillian Kuo (NIAID)

 

CANCER ANTIGEN WORKING GROUP ▼

Chair: Jose Conejo-Garcia, MD, PhD - H. Lee Moffitt Cancer Center

Co-Chair: Donald Kufe, MD - Dana-Farber Cancer Institute

 

NIH Staff Members

Kevin Howcroft (NCI)

Lillian Kuo (NIAID)

Chiayeng Wang (NIDCR)

                                                                              

IMMUNO-PREVENTION WORKING GROUP ▼

Chair: Shadmehr Demehri, MD, PhD – Massachusetts General Hospital/Harvard

Co-Chair: Steven Lipkin, MD, PhD - Weill Cornell Medicine

 

NIH Staff Members

Kevin Howcroft (NCI)

Lillian Kuo (NIAID)

Robert Shoemaker (NCI)

                                                                                                                         

IMMUNO-RADIOTHERAPY WORKING GROUP ▼

Chair: Zachary Morris, MD, PhD – University of Wisconsin - Madison

Co-Chair: Andrew Sikora, MD, PhD - Baylor College of Medicine

 

NIH Staff Members

Mansoor Ahmed (NCI)

Kory Hallett (NCI)

Kevin Howcroft (NCI)

Lillian Kuo (NIAID)

Chiayeng Wang (NIDCR)

 

TRANSLATIONAL CELLULAR THERAPY WORKING GROUP ▼

Chair: Kunle Odunsi, MD, PhD - Roswell Park Comprehensive Cancer Center

Co-Chair: Stephen Schoenberger, PhD - La Jolla Institute for Allergy and Immunology

 

NIH Staff Members

Laura Brockway-Lunardi (NCI)

Kory Hallett (NCI)

Kevin Howcroft (NCI)

Lillian Kuo (NIAID)

Connie Sommers (NCI)

Min-Kyung Song

 

IMMUNE MECHANISM WORKING GROUP ▼

Chair: Lawrence Fong, MD - University of California, San Francisco

Co-Chair: Michael Demetriou, MD, PhD - University of California, Irvine

 

NIH Staff Members

Nancy Boudreau (NCI)

Kevin Howcroft (NCI)

Lillian Kuo (NIAID)